Patients experiencing significant side effects may benefit from a slower titration schedule or temporary dose reduction, and dose escalation should be deferred while significant gastrointestinal symptoms persist
JAMA 318 (14), 13671376
IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development
DOI: Published online: February 13, 2023 1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea 2 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea 3 Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 4 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea Corresponding author: Young Min Cho
Feeling fatigued